Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Elalamy

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Journal of Thrombosis and Haemostasis : JTH|March 31, 2009
Can heparin-induced thrombocytopenia be associated with fondaparinux use? A rebuttalI Elalamy, B Tribout
British Journal of Haematology|February 21, 2006
Platelet function analyser-100 testing and primary haemostasis analysisI Elalamy, M Hatmi
Annales De Cardiologie Et D'Angeiologie|January 8, 2003
[What is the place of aspirin in venous thrombosis prophylaxis?]I Elalamy, M Hatmi
La Revue De Medecine Interne|October 5, 2010
[Aortic thrombus and splenic infarcts indicating essential thrombocythemia]C Bachmeyer, I Elalamy
Clinical and Experimental Dermatology|September 5, 2014
Rivaroxaban as an effective treatment for recurrent superficial thrombophlebitis related to primary antiphospholipid syndromeC Bachmeyer, I Elalamy
Cancer Investigation|February 9, 2018
Meeting Report EuroG20 Meeting on Cancer-Associated Thrombosis (CAT) Bergamo, Italy 7 April 2016I Elalamy, A Falanga
La Revue De Medecine Interne|April 14, 2000
[Aspirin and hemostasis]M M Samama, I Elalamy
Annales Pharmaceutiques Francaises|July 15, 2009
[Study of variability in response to aspirin and clopidogrel: clinical and/or biological resistance?]M-M Samama, I Elalamy
Journal Des Maladies Vasculaires|April 13, 2006
[Prevention of thrombosis and vascular inflammation: importance of combined cyclooxygenase and 5-lipoxygenase inhibitors]M Hatmi, M-M Samama, I Elalamy
Journal of Thrombosis and Haemostasis : JTH|February 22, 2017
Long-term treatment of cancer-associated thrombosis: the choice of the optimal anticoagulantI Elalamy, I Mahé, W Ageno, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Journal of Thrombosis and Haemostasis : JTH|March 31, 2009
Can heparin-induced thrombocytopenia be associated with fondaparinux use? A rebuttalI Elalamy, B Tribout
British Journal of Haematology|February 21, 2006
Platelet function analyser-100 testing and primary haemostasis analysisI Elalamy, M Hatmi
Annales De Cardiologie Et D'Angeiologie|January 8, 2003
[What is the place of aspirin in venous thrombosis prophylaxis?]I Elalamy, M Hatmi
La Revue De Medecine Interne|October 5, 2010
[Aortic thrombus and splenic infarcts indicating essential thrombocythemia]C Bachmeyer, I Elalamy
Clinical and Experimental Dermatology|September 5, 2014
Rivaroxaban as an effective treatment for recurrent superficial thrombophlebitis related to primary antiphospholipid syndromeC Bachmeyer, I Elalamy
Cancer Investigation|February 9, 2018
Meeting Report EuroG20 Meeting on Cancer-Associated Thrombosis (CAT) Bergamo, Italy 7 April 2016I Elalamy, A Falanga
La Revue De Medecine Interne|April 14, 2000
[Aspirin and hemostasis]M M Samama, I Elalamy
Annales Pharmaceutiques Francaises|July 15, 2009
[Study of variability in response to aspirin and clopidogrel: clinical and/or biological resistance?]M-M Samama, I Elalamy
Journal Des Maladies Vasculaires|April 13, 2006
[Prevention of thrombosis and vascular inflammation: importance of combined cyclooxygenase and 5-lipoxygenase inhibitors]M Hatmi, M-M Samama, I Elalamy
Journal of Thrombosis and Haemostasis : JTH|February 22, 2017
Long-term treatment of cancer-associated thrombosis: the choice of the optimal anticoagulantI Elalamy, I Mahé, W Ageno, et al.
Pageof 8